FDA Inspection 1307006 — The Blood Center

The Blood Center — FEI 3030823282

The FDA completed an inspection of The Blood Center on Feb 20, 2026 in Columbia, MS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 20, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Columbia, MS (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.